Correctionjust catching up on the latest news, never read this before, the rsu's are actually 1/3 per year.
(
Board of Directors Recognizes Significant Progress with RSU Grants In view of the achievement of human proof-of-concept for otenaproxesul and commercial validation, the Board of Directors is awarding 2,092,000 restricted share units (“RSUs”) to directors, officers, employees and consultants pursuant to Antibe’s RSU plan. The vesting of 50% of the RSUs granted to key executives will be subject to specific performance goals that reflect the successful execution of Antibe’s business plan, including our monetization strategy. All RSUs are subject to time-based vesting; one third (1/3) of the RSUs granted will vest on each of the first, second and third anniversaries of today’s date. In addition, we have granted BND Projects Inc. 66,000 options for investor relations services. Each option has an exercise price of $4.00, vests quarterly starting on the date of the grant, and will expire January 11, 2024.
We are excited to hit the ground running in 2021, as we embark on the next steps in developing and commercializing a new generation of anti-inflammatory drugs to meet the pressing needs of doctors and patients around the world.
Sincerely,
Dan Legault
Chief Executive Officer